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ABSTRACT: 
A sensitive, specific, precise and cost effective High 
Performance Liquid Chromatographic method of 
analysis for dipyridamole in presence of its degradation 
products is developed and validated. 
The method employed Targa C8 column i.e., (250 X 4.6 mm 
5 μm particle size) column as stationary phase. The mobile 
phase consists of acetonitrile and pH3.0 buffer in the ratio of 
35:65 %.  It is pumped through the chromatographic system 
at a flow rate of 1.2 ml/min. The UV detector is operated at 
282 nm. This system was found to 
give good resolution between dipyridamole and its 
degradation products. 
Method was validated as per ICH guidelines 
KEYWORDS: HPLC, Dipyridamole, UV detector, Targa C8 
column
INTRODUCTION: 
Dipyridamole [1] {2, 2', 2'', 2'''- (4,8- di (piperidin- 1- yl) 
pyrimido [5, 4-d] pyrimidine-2,6-diyl) bis (azanetriyl) 
tetraethano)} is platelet inhibitor. It is believed that platelet 
reactivity and interaction with prosthetic cardiac valve 
surface resulting in abnormally shortened platelet survival 
time, is significant factor in thromboembolic complications 
occurring in connection with prosthetic heart valve 
replacement.There are many methods reported for 
determination of dipyridamole in individual and combined 
dosage form, viz. Synchronous fluorescence spectrometry [2], 
Square wave voltametry [3], HPLC [4].Literature survey 
suggest that there are analytical method by HPLC for the  
estimation of dipyridamole, but the reported method for 
dipyridamole estimation have some disadvantages such as 
more retention time peak tailing.In present study, a HPLC 
method has been developed and validated with advantage of 
the retention time, cost reduction, sharp peaks and low 
solvent consumption. 
EXPERIMENTAL 
Experimental Data: 
The Acetonitrile and Methanol used are of HPLC grade, 
supplied by Ranbaxy Fine chemicals Ltd. Mohali. 
Dipyridamole, Batch No.1401457 is supplied by Panchsheel 
organics Ltd. 
Instrumentation: 
Waters 2487 gradient HPLC system with auto sampler and 
column oven (Water Alliance) was used. Separation and 
quantitation was done on Targa C8 column i.e., (250 X 4.6 
mm 5 μm particle size) column 
Chromatographic Condition: 
The mobile phase was prepared by mixing potassium 
dihydrogen phosphate, acetonitrile in the ratio of 65:35 %. 
The mobile phase was filtered using 0.45 µm Nylon filter and 
degassed in a sonicator for 10 minutes. The flow rate was 1.2 
ml.min−1.Column was maintained at 25ºC. The
 injection 
volume to carry out the chromatography was set at 20µl. 
Under these conditions dipyridamole eluted at 4.3 minute. 
The total run time was 30 minutes 
Selection of wavelength: 
Dipyridamole shows good absorbance at 282 nm so it was 
selected as wavelength of detection. 
Method Development 
Chromatographic separation of the active, related Substances 
(synthesis impurities) and its degraded products was achieved 
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using Targa C8 column i.e., (250 X 4.6 mm 5 μm particle 
size)  stainless steel column. The mobile phase was prepared 
by mixing potassium dihydrogen phosphate buffer (pH 3.0), 
acetonitrile in the ratio of 65:35 %. 
 
Standard and working solution: 
Standard solution of dipyridamole was prepared at the 
concentration of 500µg ml-1 dissolving appropriated amount 
of standard in the mobile phase. This standard solution was 
used to quantify active and final product. 
For the preparation of sample solution, 20 tablets were taken 
and weighed individually. Average weight was calculated 
and finely powdered. Appropriate portion of this powder 
equivalent to 50 mg of dipyridamole was weighed and 
transferred to a 100 ml volumetric flask. This was dissolved 
in 70 ml methanol by sonicating for 20 min and made up to 
the volume. 5 ml of above solution was pipetted into 50 ml 
volumetric flask and volume made by methanol. Filtered 
through a 0.45 µm membrane filter. 
METHOD OPTIMIZATION: 
Effect of pH: 
The effect of pH on the chromatographic behavior of the 
drug was studied by varying pH of potassium dihydrogen 
phosphate buffer to 2.8, 3.0, and 3.2. 35% acetonitrile was 
used in respective buffer at flow rate of 1.2ml/min. 
Effect of stationary phase: 
The chromatogram was recorded using following column. 
 Hypersil  C8 (250 x 4.6 mm) 5µm 
 Prontosil C8 (250 x 4.6 mm) 5µm 
 Targa C8 (250 x 4.6 mm) 5µm 
 
Effect of solvent rate: 
Different solvent namely methanol, tetrahydrofuran and 
mixture of tetrahydrofuran and methanol (1:1) in 60% of 
potassium dihydrogen phosphate buffer (pH 3.0) were used. 
Flow rate was 1.2 ml/min. 
Effect of mobile phase ratio: 
The chromatogram was recorded by using mobile phase 
containing 35%, 40%, and 55% of acetonitrile in potassium 
dihydrogen phosphate buffer (pH 3.0) 
Effect of Flow rate: 
The flow rate 1.0, 1.2, 1.4 ml/min were   used and 
chromatogram was recorded. 
Method Validation: 
Method validation was done as per ICH guidelines [5-6]. And 
accordingly the parameter evaluated were 
1. Linearity 
2. Precision 
3. Reproducibility 
4. Specificity 
5. Accuracy and 
6. System suitability 
Linearity: 
The linearity of analytical procedure is its ability (within 
given range) to obtain test results which are directly 
proportional to concentration in sample. This was studies by 
analyzing ten concentrations within the range of 12.5 µg/ml 
to 75 µg/ml solution of dipyridamole corresponding to about 
25% to 150% of target concentration. A graph was plotted in 
µg/ml on X axis versus response on Y axis 
Precision: 
The precision of analytical procedure express the closeness 
of agreement (Degree of scatter) between series of 
measurement obtained from multiple sampling of the same 
homogeneous sample under prescribed condition. The 
precision of the method was demonstrated by 
1. System Precision: Standard solution of 
dipyridamole was injected in 10 replicate injection 
and %RSD was calculated. 
2. Method Precision: Analyzing six replicate injection 
of dipyridamole standards and sample solution. 
Percentage assay of sample to that of label claim 
was calculated by comparing the sample solution 
response to that of standard solution response. 
%RSD of assay result was calculated. 
3. Intermediate Precision: Intermediate precision 
express within laboratory variation. Two analyst on 
different HPLC system conducted and analyst to 
analyst variability study by assaying six different 
test preparation of dipyridamole tablets  blend of 
same batch was calculated.  
Specificity: 
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Placebo interface:  
A study to establish the interface of tablet excipients 
(placebo) was conducted and assay was performed on 
placebo in triplicate equivalent to about the weights of the 
placebo in portion of the test method as per the method. 
Chromatogram shows no peaks at the retention time of 
dipyridamole this indicates that excipients used in the 
formulation do not interfere in the estimation of 
dipyridamole. 
Interface from the degradation product  
Interface from degradation product was carried to 
demonstrate the effective separation of degradants from 
dipyridamole. Separate portion of the drug product, drug 
substance (50µg/ml) and placebo were exposed to following 
stress condition, 
1. Refluxed with 1 N Hydrochloric acid solution at 
60ºC for about 30 min for drug substance. 
2. Refluxed with 1 N Sodium Hydroxide solution at 
60ºC solution for about 30 min for drug substance 
3. Treated with 1% hydrogen per oxide for about 30 
min on bench top 
4. Refluxed with purified water for 30 min. 
Stressed sample after appropriate dilution were injected into 
the HPLC system with diode array detector and degradant 
peaks were resolved from dipyridamole peak in the 
chromatogram of all samples. 
Accuracy: 
The accuracy of the analytical procedure express the 
closeness of the agreement between the value which accepted 
either as conventional true value or accepted reference value 
or the value found. A study recovery of dipyridamole from 
spiked placebo was conducted. Samples were prepared by 
mixing placebo, with dipyridamole raw materials equivalent 
to 50%, 75%, 100%, 125%, 150% of target concentration. 
Sample solution were prepared in triplicate for each spike 
level and assayed per method. 
System Suitability: 
System suitability is defined as, the checking of a system, 
before or during analysis of unknowns, to ensure system 
performance. A data from five injection of system precision 
(50µg/ml) were utilized for calculating system suitability 
parameter like %RSD, Tailing factor, and theoretical plates. 
Targa C8 column i.e., (250 X 4.6 mm 5 μm particle size) 
column was used as stationary phase.  The mobile phase was 
consist of  potassium dihydrogen phosphate buffer (pH 3.0), 
acetonitrile in the ratio of 65:35 % respectively .282 nm was 
detection wavelength. Flow rate was 1.2ml/min. Column run 
for 10 min at temperature of 50ºC 
Robustness: 
The robustness of analytical procedure is a measure of its 
capacity to remain unaffected by small, but deliberate 
variation in method parameter and provides an indication of 
its reliability during normal usage and done by changing,  
1. Influence of variation of pH in the mobile phase 
(±0.2)  
2. Influence of variation of flow rates (±10%). 
Ruggedness (System to system variation) 
Ruggedness of analytical method is degree of reproducibility 
of test result obtained by the analysis of the same sample 
under verity of condition such as laboratory, analyst and 
instruments. System to system variation was conducted on 
two HPLC systems by using the same column by assaying 
six different test preparation of dipyridamole blend 
(50µg/ml) as per method 
Filter Validation: 
A study to establish the suitability of filter was conducted 
using two different filters namely 0.45µm PVDF filter and 
0.45µm Nylon filter. Test preparation were prepared in 
triplicate were centrifuged and filtered through different 
filters, were assayed against unfiltered standards 
(50µg/ml).The difference in % assay values between 
centrifuged and filtered sample were calculated.  
RESULT AND DISCUSSION: 
HPLC method development and optimization of 
dipyridamole: 
Effect of pH: 
The retention time of dipyridamole was decreased as the pH 
of mobile phase increased. This may be due to ionized state 
of dipyridamole at higher pH.  For the pH 2.8, pH 3.0 and pH 
3.2 retention time was 3.8, 4.2 and 4.2; hence pH 3.0 buffer 
was selected since it gave the retention time of around 4.2 
min.   
Effect of the stationary Phase: 
On Targa C8 (25 cm x 4.6 mm) 5µm , dipyridamole eluted 
with desirable retention and symmetrical peak. For the study 
Targa C8 (25 cm x 4.6 mm) 5µm was selected because of its 
lower asymmetric factor (i.e 1.3) when compared to other 
column. Also with Hypersil C8 columns  tailing factor was 
more and peak shape was irregular and hence we have 
selected Targa C8 column. 
Effect of solvent strength: 
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Different solvent like methanol acetonitrile, in potassium 
dihydrogen phosphate buffer (pH 3.0) were used at flow rate 
of 1.2 ml/min. When methanol was used, peak broadening 
was observed along with the high back pressure. With the 
methanol and water peak tailing was observed. For the 
present study, 35% acetonitrile in potassium dihydrogen 
phosphate buffer (pH 3.0) was selected because it gave good 
separation. 
Effect of Ratio of mobile phase: 
The proportion of acetonitrile and potassium dihydrogen 
phosphate buffer (pH 3.0) of 70:30, 45:55, 35:65 %v/v were 
used as mobile phase. At 35:65 %v/v ratio of acetonitrile and 
potassium dihydrogen phosphate buffer (pH 3.0), a 
symmetrical peak eluted at around 4.0 min with good 
capacity factor and it was selected as for further studies. 
Effect of Flow rate: 
The entire selected flow rate (i.e. 1.0 ml/min, 1.2 ml/min, and 
1.4 ml/min) gave symmetrical peak with acceptable capacity 
factor. For the present study 1.2 ml/min was selected on the 
basis of less retention time (5.1), good peak shape, 
Acceptable back pressure and better separation of impurities 
from drug.  
HPLC assay method validation dipyridamole: 
Specificity: 
Assay was performed on placebo in triplicate equivalent to 
about the weights of placebo in portion of test preparation as 
per test methods. Chromatograms of placebo solution showed 
no peaks at the retention time of dipyridamole and its 
degradation product. This indicates the excipients used in 
formulation do not interfere in the estimation of 
dipyridamole. 
2. Interference with the degradation products 
The Dipyridamole peak was well resolved from the degraded 
impurities. The peak purity test of dipyridamole at the stress 
condition had revealed that the method was stability 
indicating and specific. The result was summarized in the 
figure 2. 
Solution stability: 
A solution of dipyridamole (50µg/ml) was prepared and 
stored at room temperature for 24 hrs. The sample solution 
withdrawn at intervals of 0, 2, 4, 6, 8, 12 and 24 hrs and 
analyzed. No additional peak was observed in the solution 
that was kept for 24 Hrs. 
Precision: 
System Precision: 
The % RSD of repeated injection was found to 0.4 % it was 
found to be within the acceptable value of 1.0% hence 
proposed method was precise. Results are given in table 1. 
Method Precision: 
The precision of test method was evaluated by assaying six 
sample of dipyridamole tablet blend 
(50µg/ml).The mean % assay was found to be 100.2% and 
%RSD of assay was found to be 1.3%. Results are given in 
the table 1. 
Intermediate Precision 
Two analyst on different HPLC system conducted analyst to 
analyst variability study by assaying six different test 
preparation of dipyridamole tablet blend. The average 
%assay obtained by both analysts was found to be 98.7 and 
98.7 with RSD of 1.4% and 1.3% respectively .The system 
suitability parameter were evaluated as per method by both 
analyst and found to be within limits. The limits are 
summarized in the table 1. 
Linearity: 
The data obtained in linearity experiments was subject to 
linear regression analysis. The coefficient of regression (r2) 
was found to be 0.9998. Linearity data and plot are reported 
in the table 1. 
 
Accuracy  
The results from recovery study for accuracy determination 
are depicted in the Table 1. Recovery of dipyridamole from 
spiked placebo was conducted. Sample solution was analyzed 
in triplicate for each concentration level and assayed as per 
method. The percentage recovery was found to be within the 
limits (97.5-100.4%). The mean recovery of dipyridamole 
tablet should not be less than 97% and not more than 103%. 
Robustness: 
No significant change in the chromatographic parameters 
were observed when change in the optimized condition like 
change in the pH and flow rates. The results are summarized 
in the table 1. 
Ruggedness: 
System to System variability: 
System to system variability was conducted by two HPLC 
systems by using same column by assaying six different test 
preparation of dipyridamole blend in same condition. The 
system suitability parameter found to be within limits. The 
average assay for system was found to be 98.7 and 98.7 with 
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RSD of 1.4% and 1.3% respectively. Comparison of the 
result obtained on two system shows that the assay method is 
rugged for system to system variability. System suitability 
parameters, assay results are summarized in the table 1. 
Filter Validation: 
A study to establish the suitability of filter was conducted 
using two different filters namely 0.45µm PVDF filter and 
0.45 µm nylon 66 filters. Test preparation in triplicate were 
centrifuged and filtered through either filters, were assayed 
against unfiltered standards. The difference in the %assay 
values between centrifuged and filtered samples within to be 
within limits. This study indicates that both filters are 
suitable for filtration.  
System Suitability: 
All the values  of parameter i.e. USP plate count (4002), USP 
tailing (1.3) and %RSD of six replicate injections (0.1%) of 
system suitability were found to be within in the acceptable 
limits. It concluded that the method and systems are adequate 
for the analysis to be performed.
 
Table1: validation Parameter: 
Parameter Obtained Results 
r
2
 0.9998 
Accuracy (% RSD) Recovery 
levels 
50% 97.7 ± 0.21 % 
75% 98.3 ±1.51 % 
100% 99.6 ± 0.70 % 
125% 98.2 ± 0.82 % 
150% 100.3 ± 0.07% 
Assay 101.1 % w/w 
Precision (% RSD) System Precision 0.42 % 
Intermediate 
Precision 
Analyst 1 1.6 % 
Analyst 2 1.5 % 
Method Precision 1.3 % 
Robustness (% RSD) Effect of 
variation in 
pH 
pH 2.8 0.16 % 
pH 3.0 0.10 % 
pH 3.2 0.20 % 
Effect of 
variation in  
flow rate 
1.0 ml/min 0.07 % 
1.2 ml/min 0.09 % 
1.4 ml/min 0.07 % 
Ruggedness System to 
system 
variability 
System 1 1.4 % 
System 2 1.3 % 
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Fig 1: representative chromatogram of the dipyridamole under optimized condition 
 
Fig 2: Interference of degradation Product 
CONCLUSION: 
The ultimate Goal of the validation process is to challenge 
the method and determine limits of allowed variability for the 
condition needed to run the method.The proposed analytical 
method has been proved to be simple, specific and accurate 
which fulfill all the parameters of the validation (table 4). 
Therefore this method has been successfully applied to raw 
materials and dosage form like tablets. 
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